Cyclosporine Dose, Serum Trough Levels, and Allograft Preservation in a Rat Model of Laryngeal Transplantation

Using a rat model of laryngeal transplantation, we sought to define the relationships between acute laryngeal rejection grade (RG) and cyclosporin A (CSA) concentration and CSA dosage. Five recipient Lewis rat groups (N = 10 per group) were administered intramuscular CSA doses of 1.0 (group 1), 2.5 (group 2), 5.0 (group 3), 7.5 (group 4), and 10 mg/kg per day (group 5) for 14 days. Immediately before sacrifice, 5 mL of whole blood was obtained to assay CSA trough levels by high-performance liquid chromatography. The specimens were graded microscopically by blinded reviewers by day of RG, 0 to 14 days after transplantation, as described in earlier reports. Despite high intragroup variability in CSA levels, significantly different mean CSA concentrations were achieved among all CSA dosage groups: 1,2,3,4, and 5 (.0001 < p < .02). The mean laryngeal RGs did not test significantly different from each other with groups 3, 4, and 5 (RG, 2.3 ± 1.3 versus 1.9 ± 1.1 versus 1.7 ±0.3, respectively, .2 < p < .6). The RG for group 1 was significantly greater than those for groups 2 through 5 (p < .001), and the group 2 RG was greater (p < .02) than those for groups 3, 4, and 5. Polynomial fitting was used to determine the continuous relationship between each individual specimen's CSA concentration and the RG. Significant pathological allograft rejection correlated with CSA concentrations below 250 ng/mL.

[1]  W. Braun,et al.  Laryngeal transplantation and 40-month follow-up. , 2001, The New England journal of medicine.

[2]  M Rowland,et al.  Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[3]  S. Sakuma,et al.  Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival , 1999, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  B. Griffith,et al.  Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation. , 1998, The Journal of thoracic and cardiovascular surgery.

[5]  S. Sellam,et al.  Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study. , 1995, The Journal of Heart and Lung Transplantation.

[6]  S. Strome,et al.  The effects of cyclosporin a on transplanted rat allografts , 1993, The Laryngoscope.

[7]  S. Strome,et al.  Histopathologic Correlates of Acute Laryngeal Allograft Rejection in a Rat Model , 1992, Annals of Otology, Rhinology and Laryngology.

[8]  S. Bolling,et al.  PROLONGATION OF CARDIAC ALLOGRAFT SURVIVAL IN RATS BY ANTI‐TNF AND CYCLOSPORINE COMBINATION THERAPY , 1992, Transplantation.

[9]  S. Money,et al.  The effects of cyclosporine on varying segments of small-bowel grafts in the rat. , 1988, Surgery.

[10]  B. Langer,et al.  PHARMACOKINETIC PROFILES OF CYCLOSPORINE IN RATS: INFLUENCE OF ROUTE OF ADMINISTRATION AND DOSAGE , 1985, Transplantation.

[11]  D. C. Martin,et al.  COMPOSITE TISSUE (LIMB) ALLOGRAFTS IN RATS: I. DOSE‐DEPENDENT INCREASE IN SURVIVAL WITH CYCLOSPORINE , 1985, Transplantation.